Cargando…
Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies
Biomarkers are important tools in clinical diagnosis and prognostic classification of various cutaneous malignancies. Besides clinical and histopathological aspects (e.g. anatomic site and type of the primary tumour, tumour size and invasion depth, ulceration, vascular invasion), an increasing varie...
Autores principales: | Utikal, Jochen, Schadendorf, Dirk, Ugurel, Selma |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1800369/ https://www.ncbi.nlm.nih.gov/pubmed/17221215 http://dx.doi.org/10.1007/s00403-006-0726-5 |
Ejemplares similares
-
Dose-dependent severe cutaneous reactions to imatinib
por: Ugurel, S, et al.
Publicado: (2003) -
Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations
por: Cosgarea, Ioana, et al.
Publicado: (2017) -
Tackling malignant melanoma epigenetically: histone lysine methylation
por: Orouji, Elias, et al.
Publicado: (2018) -
STAT3 Single Nucleotide Polymorphism rs4796793 SNP Does Not Correlate with Response to Adjuvant IFNα Therapy in Stage III Melanoma Patients
por: Schrama, David, et al.
Publicado: (2014) -
Established and Emerging Biomarkers in Cutaneous Malignant Melanoma
por: Verykiou, Stamatina, et al.
Publicado: (2014)